Samsung Biologics Reports 26% Increase in 2024 Net Profit Amid Record Sales
Seoul: Samsung Biologics Co., a biotech arm of South Korea’s Samsung Group, announced a significant financial milestone on Wednesday, reporting a 26.3 percent year-on-year increase